Frijlink HW - Search Results

1

Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or Trileucine.

Sibum I, Hagedoorn P, Kluitman MPG, Kloezen M, Frijlink HW, Grasmeijer F. Sibum I, et al. Among authors: frijlink hw. Pharmaceutics. 2019 Dec 25;12(1):24. doi: 10.3390/pharmaceutics12010024. Pharmaceutics. 2019. PMID: 31881695 Free PMC article.

2

The rate of drug particle detachment from carrier crystals in an air classifier-based inhaler.

de Boer AH, Hagedoorn P, Gjaltema D, Lambregts D, Irngartinger M, Frijlink HW. de Boer AH, et al. Among authors: frijlink hw. Pharm Res. 2004 Dec;21(12):2158-66. doi: 10.1007/s11095-004-7668-4. Pharm Res. 2004. PMID: 15648246

3

The mode of drug particle detachment from carrier crystals in an air classifier-based inhaler.

de Boer AH, Hagedoorn P, Gjaltema D, Lambregts D, Irngartinger M, Frijlink HW. de Boer AH, et al. Among authors: frijlink hw. Pharm Res. 2004 Dec;21(12):2167-74. doi: 10.1007/s11095-004-5171-6. Pharm Res. 2004. PMID: 15648247

4

Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.

de Boer AH, Hagedoorn P, Westerman EM, Le Brun PP, Heijerman HG, Frijlink HW. de Boer AH, et al. Among authors: frijlink hw. Eur J Pharm Sci. 2006 Jun;28(3):171-8. doi: 10.1016/j.ejps.2005.11.013. Epub 2006 Mar 8. Eur J Pharm Sci. 2006. PMID: 16650739

5

In vitro performance testing of the novel Medspray wet aerosol inhaler based on the principle of Rayleigh break-up.

de Boer AH, Wissink J, Hagedoorn P, Heskamp I, de Kruijf W, Bünder R, Zanen P, Munnik P, van Rijn C, Frijlink HW. de Boer AH, et al. Among authors: frijlink hw. Pharm Res. 2008 May;25(5):1186-92. doi: 10.1007/s11095-007-9503-1. Epub 2007 Dec 8. Pharm Res. 2008. PMID: 18066714 Free PMC article.

6

Comparative in vitro evaluation of four corticosteroid metered dose inhalers: Consistency of delivered dose and particle size distribution.

de Vries TW, Rottier BL, Gjaltema D, Hagedoorn P, Frijlink HW, de Boer AH. de Vries TW, et al. Among authors: frijlink hw. Respir Med. 2009 Aug;103(8):1167-73. doi: 10.1016/j.rmed.2009.02.010. Epub 2009 Mar 9. Respir Med. 2009. PMID: 19269801 Free article.

7

In vivo performance testing of the novel Medspray wet aerosol inhaler.

Munnik P, de Boer AH, Wissink J, Hagedoorn P, Heskamp I, de Kruijf W, van Rijn CJ, Frijlink HW, Zanen P. Munnik P, et al. Among authors: frijlink hw. J Aerosol Med Pulm Drug Deliv. 2009 Dec;22(4):317-21. doi: 10.1089/jamp.2008.0723. J Aerosol Med Pulm Drug Deliv. 2009. PMID: 19425829 Clinical Trial.

8

A centrifuge method to measure particle cohesion forces to substrate surfaces: the use of a force distribution concept for data interpretation.

Nguyen TT, Rambanapasi C, de Boer AH, Frijlink HW, Ven PM, de Vries J, Busscher HJ, Maarschalk Kv. Nguyen TT, et al. Among authors: frijlink hw. Int J Pharm. 2010 Jun 30;393(1-2):88-95. doi: 10.1016/j.ijpharm.2010.04.016. Epub 2010 Apr 20. Int J Pharm. 2010. PMID: 20412844

9

Characterisation of high dose aerosols from dry powder inhalers.

Grasmeijer F, Hagedoorn P, Frijlink HW, de Boer AH. Grasmeijer F, et al. Among authors: frijlink hw. Int J Pharm. 2012 Nov 1;437(1-2):242-9. doi: 10.1016/j.ijpharm.2012.08.020. Epub 2012 Aug 19. Int J Pharm. 2012. PMID: 22939966

10

Aspartate buffer and divalent metal ions affect oxytocin in aqueous solution and protect it from degradation.

Avanti C, Oktaviani NA, Hinrichs WL, Frijlink HW, Mulder FA. Avanti C, et al. Among authors: frijlink hw. Int J Pharm. 2013 Feb 28;444(1-2):139-45. doi: 10.1016/j.ijpharm.2013.01.051. Epub 2013 Feb 1. Int J Pharm. 2013. PMID: 23376504 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page